Campbell & Co Investment Adviser’s Pfizer PFE Stock Holding History

Campbell & Co Investment Adviser’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.81M	Buy	+75,099	New	+$1.96M	0.09%	355
2026 Q1	–	Sell	-90,977	Closed	-$2.27M	–	1341
2025 Q4	$2.27M	Sell	90,977 -41,547	-31%	-$1.05M	0.11%	290
2025 Q3	$3.38M	Buy	132,524 +118,192	+825%	+$2.92M	0.26%	82
2025 Q2	$347K	Sell	14,332 -43,434	-75%	-$1.01M	0.02%	910
2025 Q1	$1.46M	Buy	57,766 +50,176	+661%	+$1.31M	0.11%	283
2024 Q4	$201K	Sell	7,590 -74,906	-91%	-$2.03M	0.02%	968
2024 Q3	$2.39M	Buy	+82,496	New	+$2.41M	0.18%	145
2024 Q2	–	Sell	-41,400	Closed	-$1.15M	–	1281
2024 Q1	$1.15M	Buy	+41,400	New	+$1.15M	0.1%	337
2023 Q1	–	Sell	-7,812	Closed	-$400K	–	983
2022 Q4	$400K	Sell	7,812 -847	-10%	-$40.6K	0.1%	418
2022 Q3	$379K	Buy	+8,659	New	+$421K	0.09%	403
2021 Q4	–	Sell	-19,550	Closed	-$841K	–	768
2021 Q3	$841K	Buy	19,550 +8,550	+78%	+$379K	0.27%	94
2021 Q2	$431K	Buy	+11,000	New	+$428K	0.18%	197
2020 Q1	–	Sell	-13,173	Closed	-$490K	–	376
2019 Q4	$490K	Buy	+13,173	New	+$469K	0.15%	238
2014 Q1	–	Sell	-242,073	Closed	-$7.04M	–	277
2013 Q4	$7.04M	Buy	+242,073	New	+$7.05M	1.58%	4

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Campbell & Co Investment Adviser's PFE Position: Q2 2026 in Review

Campbell & Co Investment Adviser opened a new position in Pfizer (PFE) in Q2 2026: 75,099 shares worth $1.81M. The stake represents 0.09% of the portfolio and ranks #355 among its holdings. This is a return to the name: Campbell & Co Investment Adviser previously reported a position in PFE as recently as Q4 2025.

Campbell & Co Investment Adviser first reported a position in PFE in Q4 2013 and has held it in 14 quarters since. The position peaked at $7.04M in Q4 2013. 2,834 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Campbell & Co Investment Adviser held 75,099 shares of Pfizer worth $1.81M as of Q2 2026.
Pfizer was a new Campbell & Co Investment Adviser position in Q2 2026.
Pfizer made up 0.09% of Campbell & Co Investment Adviser's portfolio in Q2 2026, its #355 holding.
Campbell & Co Investment Adviser first reported a position in Pfizer in Q4 2013 and has held it in 14 quarters since.
Campbell & Co Investment Adviser's Pfizer position peaked at $7.04M in Q4 2013.
2,834 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Campbell & Co Investment Adviser's 13F filing for Q2 2026, filed 3 Aug 2026.